Celestica Inc vs Procter & Gamble Co — how do they compare? Celestica Inc trades at $310.99 (market cap $39.77B), while Procter & Gamble Co trades at $145.12 (market cap $340.39B). The key difference: Procter & Gamble Co is far larger — about 8.6× Celestica Inc's market cap, and Procter & Gamble Co pays a 2.97% dividend while Celestica Inc pays none. Which is the better fit depends on your goals.
| CLS | PG | |
|---|---|---|
Market Cap | $39.77B | $340.39B |
Sector | Technology | Consumer Staples |
52-Week High | $472.40 | $167.18 |
52-Week Low | $181.34 | $138.10 |
Enterprise Value | $40.05B | $366.23B |
Volume | — | 6,423,436 |
Dividend Yield | — | 2.97% |
Signals from Pluang's Aura AI — not financial advice
CLS trades at $317.83, up 1.05% today, with strong earnings momentum after beating estimates in Q4 2025, Q1 2026, and Q2 2026. Technical indicators show a bearish trend with support at $309 and resistance at $323. The company reported $12.39B revenue in 2025 with net income of $832.5M, supported by robust cash flow from operations of $659.5M. Recent news highlights a $3B equity offering to fund AI infrastructure growth, though it may cause near-term dilution.
Outlook is positive with analyst consensus price target of $455.33 (43% upside), but risks include equity dilution from the offering and premium valuations (P/E 36.4). Growth catalysts are strong AI-driven demand and expanding partnerships, making CLS a compelling pick for investors seeking exposure to data center infrastructure, albeit with volatility near-term.
Procter & Gamble (PG) trades at $145.21, down 0.39% on the day, with a bearish technical signal but strong fundamentals. The stock shows consistent earnings beats, with Q2 2026 EPS of $1.43 exceeding expectations, and a robust 18.44% net income margin. Recent news highlights its dividend reliability and supply chain improvements, while analyst consensus is bullish with a $161.20 price target.
Outlook remains positive due to steady profitability and dividend growth, but risks include premium valuation and economic sensitivity. Investors may find value in its defensive qualities amid market volatility, though near-term upside could be limited by technical resistance and modest revenue growth projections.
Trailing returns across standard periods
Latest headlines on both assets
Celestica provides supply chain and manufacturing solutions for global technology companies. It specializes in high-complexity assembly and platform solutions for AI data centers, aerospace, and medical markets.
Read more on CLS →The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →